📊 Score Breakdown
Offering Ability
60
Cash Runway
10
Float Risk
100
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
53%
📜 Warrant Exercise
60%
• Massive warrant overhang: 1224% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration
50%
• Score rose 39 points recently (worsening)
• Score in HIGH risk zone (71/100)
🔁 Convertible Conversion
40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
💹 Market Data
Market Cap$2.01M
Shares Outstanding653.1K
Float30.0K
Cash$6.07M
Debt$10.10M
Short InterestN/A
🏛 Institutional Holdings
1 institutional holders · 1.7K shares
#1
UBS Group AG
1.7K shares
📉 Short Interest
Short Interest24.0K
Days to Cover1.0
% of Float79.9%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for JFBR
📊 JFBR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 JFBR Signal Convergence & Dark Pool Activity — StonkWhisper
📄 JFBR Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.